2006 SGO Annual Meeting on Women's CancerWHAT: The Society of Gynecologic Oncologists 37th Annual Meeting on Women's Cancer is the preeminent educational and scientific event for physicians and health care professionals involved in the field of gynecologic oncology. In addition to the Society of Gynecologic Oncologists (SGO) large member base, this important meeting attracts medical and radiation oncologists, pathologists and gynecologic nurse oncologists from all over the country.
Attendees present and discuss the latest research findings in the field of gynecologic oncology that help to inform practice and care. More than 400 studies will be presented at the meeting -- all abstracts being presented at the meeting can be viewed online at www.sgo.org. All studies are embargoed until the day and time they are presented. Here are a few highlights:
EMBARGOED FOR RELEASE UNTIL 8:00 a.m., PST, Friday, March 24, 2006
- In one of the first trials to combine a biologic agent with a conventional chemotherapy agent for the treatment of ovarian cancer, researchers found a significant increase in the response to therapy and the duration of progression free survival without additional toxicity.
EMBARGOED FOR RELEASE UNTIL 10:30 a.m., PST, Friday, March 24, 2006
- In the largest study of its kind, researchers will present new criteria for detecting ovarian cancer malignancy in postmenopausal asymptomatic women, 55 to 74 years old. Utilizing the new criteria, researchers determined that they could accurately predict 93 percent of the advanced ovarian cancers and 87 percent of the early ovarian cancers in asymptomatic women enrolled in an annual screening program and found to have an abnormal screen.
WHEN: March 22-26, 2006
WHERE: Palm Springs Convention Center in Palm Springs, California
Last reviewed: By John M. Grohol, Psy.D. on 30 Apr 2016
Published on PsychCentral.com. All rights reserved.